kidney stones and glp-1 Renal effects of receptor agonists tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine A Rise in Kidney Stones

Emerging Metabolic Therapies Advancements in metabolic health continue to evolve, including therapies that target GLP-1 and GIP pathways

Understanding how the medication works, how responses vary, and what to watch for early on empowers you to engage confidently with your care plan

Hashimotos thyroiditis affects about 1 to 2 percent of people in the United States, according to the National Institutes of Health

The needles used for subcutaneous injection are thin and short, designed to minimize discomfort

Biochemical pharmacology , 79 (7), 1000-1006

The SELECT trial, published in 2024, showed that semaglutide reduced major adverse cardiovascular events (MACE: heart attack, stroke, cardiovascular death) by 20% in individuals with obesity, even independent of weight loss magnitude. Why